Floatz logo

Cytosin-Arabinosid

Efficiency

The Affiliated Hospital of the Chinese Academy of Military Medical SciencesPhase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Efficiency cohort.

Asset / SponsorPhaseRating
Idarubicine
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Phase 1CC
FILGRASTIM
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Phase 1CC

Same molecule, other indications

Cytosin-Arabinosid is also rated in:

acute promyelocytic leukemiaDormant
A
Indicative ·
82 / 100
View asset →
adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →